logo

QNTM’s Debt-to-Equity Ratio at 0.22: What It Means for Quantum BioPharma Ltd’s Future

Quantum BioPharma Ltd had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $24.76 on 05/28/24, while the lowest price during the same period was $2.70 on 12/20/24.

52-week price history of QNTM Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Quantum BioPharma Ltd’s current trading price is -50.48% away from its 52-week high, while its distance from the 52-week low is 354.07%. The stock’s price range for this period has remained between $2.70 and $24.76. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.59 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.57 million over the last three months.

Financial Performance and Market Capitalization

Quantum BioPharma Ltd (QNTM) has experienced a quarterly rise of 43.39% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 28.20M and boasts a workforce of 7 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 6.26, with a change in price of +9.26. Similarly, Quantum BioPharma Ltd recorded 1,773,701 in trading volume during the last 100 days, posting a change of +308.67%.

QNTM Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for QNTM stands at 0.22. Similarly, the long-term debt-to-equity ratio is also 0.00.

QNTM Stock Stochastic Average

As of today, the raw stochastic average of Quantum BioPharma Ltd over the past 50 days is 94.38%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 92.87%. Additionally, the Stochastic %K and %D values for the company were 93.90% and 84.83%, respectively, over the past 20 days.

QNTM Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price increase of 233.15%. However, over the past six months, we’ve seen a weaker performance of 131.76%. The price of QNTM fallen by 94.60% over the last 30 days. And in the last five days, it has surged by 34.43%.

Most Popular